NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS

Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS explained in plain language.

Never miss a new study

Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS trials appear

Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill aims to prevent liver failure in NASH patients

Disease control Ongoing

This study tests whether a daily pill called resmetirom can prevent serious liver problems in people with NASH-related cirrhosis (scarring of the liver). About 845 adults with well-compensated cirrhosis (still functioning liver) will receive either the drug or a placebo for sever…

Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS

Phase: PHASE3 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 08, 2026 13:11 UTC

NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS

Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS trials appear

New pill aims to prevent liver failure in NASH patients